Clinical Trials Browser

Phase 2/3 × Astrocytoma × Bevacizumab × Clear all

NCT01236560 2024-02-20

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

Phase 2/3 Completed

101 enrolled 15 charts

Astrocytoma, Spinal Cord Neoplasms

NCT02414165 2020-02-07

Toca5

Phase 2/3 Terminated

Astrocytoma, Glioblastoma, Recurrence